FLNA
FILANA THERAPEUTICS, INC.
+0.03 (+4.15%)0.71USD135K成交股數34.2M市值–本益比(近四季)0.8股價營收比–營收年增(近四季)2026-10-29下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 4.5M | 3.9M | 4.0M | 5.1M | 13.7M | 17.7M | 15.2M | 16.2M | 18.7M | 23.6M | 25.0M | 22.1M |
| 銷售管理費用 | 6.6M | 9.7M | 7.9M | 40.3M | 10.9M | 12.9M | 46.2M | 3.7M | 4.1M | 4.3M | 3.8M | 4.4M |
| 營業利益 | −11.2M-55% | −13.6M-56% | −11.9M-81% | −45.4M+128% | −24.6M+8% | −30.6M+10% | −61.4M+113% | −19.9M-25% | −22.8M | −27.9M | −28.8M | −26.5M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −10.3M-56% | −12.5M-55% | −10.8M-276% | −44.2M-277% | −23.4M+12% | −27.9M+9% | 6.2M-123% | 25.0M-203% | −20.9M | −25.7M | −26.4M | −24.3M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | – | -0.26-55% | -0.22-269% | -0.92+114% | -0.48-4% | -0.58-5% | 0.13-121% | -0.43-26% | -0.50 | -0.61 | -0.63 | -0.58 |
| 稀釋股數 | – | 48.3M | 48.3M | 48.3M | 48.3M | 48.0M | 46.2M | 44.1M | 41.9M | 42.0M | 41.8M | 41.7M |
資產負債表 期末餘額
| 科目 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 86.6M | 95.5M | 106M | 112M | 117M | 149M | 207M | 124M | 121M | 142M | 168M | 187M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 108M | 118M | 130M | 135M | 141M | 224M | 244M | 156M | 152M | 173M | 197M | 218M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 40.2M | 44.0M | 48.2M | 47.4M | 13.3M | 57.1M | – | – | 14.2M | 17.4M | 17.9M | 14.1M |
| 股東權益 | 68.1M | 74.4M | 81.6M | 88.0M | 128M | 167M | 189M | 78.6M | 137M | 155M | 179M | 204M |
| 負債比 | 37.1% | 37.1% | 37.1% | 35.0% | 9.4% | 25.5% | – | – | 9.4% | 10.1% | 9.1% | 6.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | −8.9M-22% | – | – | – | −11.3M | – | – | −19.1M+44% | – | – | – | −13.3M |
| 資本支出 | – | – | – | – | 0.00 | – | – | 0.00 | – | – | – | 357K |
| 自由現金流 | – | – | – | – | −11.3M | – | – | −19.1M+41% | – | – | – | −13.6M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −91.0M | –% | -1.88 | −32.8M |
| FY2024 | – | – | −24.3M | –% | -1.46 | −117M |
| FY2023 | – | – | −97.2M | –% | -2.32 | −82.4M |
| FY2022 | – | – | −76.2M | –% | -1.90 | −80.2M |
| FY2022 | – | – | – | –% | – | – |
| FY2021 | – | – | −32.4M | –% | -0.82 | −52.4M |
| FY2020 | – | – | −6.3M | –% | -0.24 | – |
| FY2019 | – | – | −4.6M | –% | -0.27 | −2.5M |